Search Results 71-80 of 14792 for anti-TNF drugs

1. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

2. Breast cancer chemoprevention: Drugs that reduce risk - Mayo Clinic

   Preventive medications can reduce breast cancer risk. Learn about how these drugs work, who should consider taking them, plus their side effects and health ...

3. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

4. A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors - Mayo Clinic

   Previous treatment with tocilizumab or etanercept. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

5. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

6. Infliximab (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

   ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...

8. Hidradenitis Suppurativa Clinical Trials - Mayo Clinic Research

   ... Anti‑TNF Therapy. Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic Therapy. Hidradenitis Suppurativa Global ...

9. Clinical Trials - Mayo Clinic Research

   Title: A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe ...

10. A Study of Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... etanercept for the treatment of patients with psoriatic arthritis (PsA).